Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: government – Page 132

Circa 2018: In January 2017, while one of us was serving as a homeland security advisor to outgoing President Barack Obama, a deadly pandemic was among the scenarios that the outgoing and incoming U.S. Cabinet officials discussed in a daylong exercise that focused on honing interagency coordination and rapid federal response to potential crises. The exercise is an important element of the preparations during transitions between administrations, and it seemed things were off to a good start with a commitment to continuity and a focus on biodefense, preparedness, and the Global Health Security Agenda—an initiative begun by the Obama administration to help build health security capacity in the most critically at-risk countries around the world and to prevent the spread of infectious disease. But that commitment was short-lived.

Deadly diseases like Ebola and the avian flu are only one flight away. The U.S. government must start taking preparedness seriously.

Read more | >

An interesting opinion:

The US Government Comparative Toxicogenomics database shows that Fluoride can inhibit Human immunity to viruses and pneumonia. Angiotensin I-Converting Enzyme (ACE), 2’-5’-Oligoadenylate Synthetase 1 (OAS1) and Intercellular Adhesion Molecule 1 (ICAM1) are included as susceptible epigenetic targets of the poison.

Read 3 answers by scientists with 1 recommendation from their colleagues to the question asked by Geoff Pain on Feb 4, 2020.

Read more | >

The rescue package contains specific measures to address the spike in unemployment claims.

“It is reasonable to expect that some, perhaps many, but not all, of these jobs will come back once we venture back into public,” Mark Hamrick, senior economic analyst at Bankrate.com, said. “One of the goals of the legislation now moving through Congress is to help many businesses survive and retain workers.”

“It’s beyond anything we have ever seen. It’s the speed that is so painful,” Swonk said.

Read more | >

Healthcare professionals and infectious disease experts around the world agree that extensive testing is the best way to combat coronavirus. However, the extreme shortage of COVID-19 testing kits has made that impossible. The Public Health England (PHE) just announced it was planning to begin rolling out at-home COVID-19 testing kits in the coming days. These tests could tell people if they’ve been infected with COVID-19 in as little as 15 minutes.

Current coronavirus testing is time-consuming and expensive because it requires healthcare practitioners to collect samples from the patient and have them processed in a laboratory. The test promised by the UK government would look like a pregnancy test and needs just a drop of blood to diagnose the individual.

Several companies are working on at-home COVID-19 tests, but PHE didn’t say which test it planned to deploy. According to PHE, the unnamed test takes 15 minutes to work, and it will be available at pharmacies and online via retailers like Amazon. The test will detect antibodies in the user’s blood that indicate they have been exposed to the SARS-CoV-2 virus. It works with both Immunoglobulin M and Immunoglobulin G (IgM and IGG) type antibodies. IgM peaks early in an infection and IgG remains even after the infection has subsided.

Read more | >

Coronavirus RNA survived for up to 17 days aboard the Diamond Princess cruise ship, living far longer on surfaces than previous research has shown, according to new data published Monday by the Centers for Disease Control and Prevention.

The study examined the Japanese and U.S. government efforts to contain the COVID-19 outbreaks on the Carnival-owned Diamond Princess ship in Japan and the Grand Princess ship in California. Passengers and crew on both ships were quarantined on board after previous guests, who didn’t have any symptoms while aboard each of the ships, tested positive for COVID-19 after landing ashore.

The RNA, the genetic material of the virus that causes COVID-19, “was identified on a variety of surfaces in cabins of both symptomatic and asymptomatic infected passengers up to 17 days after cabins were vacated on the Diamond Princess but before disinfection procedures had been conducted,” the researchers wrote, adding that the finding doesn’t necessarily mean the virus spread by surface.

Read more | >

As the COVID-19 cases continue to rise globally, the National Medical Products Administration of China has approved the first-ever antiviral medicine called Favilavir. This medicine is said to possibly treat the now-declared pandemic illness.

Over the weekend, Taizhou’s city government announced that Favilavir, which was initially formulated by a Chinese-owned pharmaceutical firm, is the first medicine authorized to stop the widespread of this fatal illness. At present, this drug is being promoted with the label, Avigan.

According to the Ministry of Science and Technology of China, the Favilavir of Hisun Pharmaceutical is among the three drugs that have presented results for hindering COVID-19 (in initial trials) from spreading and further damaging the health of the people worldwide.

Read more | >

By Bill D’Zio

Chart prepared by WestEastSpace.com of Seat cost over time for Soyuz purchased seats.
*Notes *1 In February 2017, NASA purchased from Boeing two Soyuz seats and then later three additional seats for $373.5 million or $74.7 million per seat. Boeing had the rights to sell the seats as a result of a settlement with RSC Energia—the Russian company that builds the Soyuz for Roscosmos—due to a failed partnership to develop the capability to launch rockets from an off-shore platform in the ocean.
2 2017 NASA contract for 12 additional seats
3 Due to slippage in the commercial crew schedule, in March 2018 NASA purchased two additional Soyuz seats for $86 million each, one for the September 2019 Soyuz flight and another on the upcoming April 2020 mission.
4 One Soyuz launch failed during launch requiring an abort prior to reaching orbit. Data Source: NASA Office of Inspector General analysis of Soyuz cost data provided by NASA

Soyuz creeping up in cost

NASA has been dependent on Russia for transport to and from the ISS. Over time the cost of seats on the Soyuz crew vehicle have risen.

Continue reading “Final NASA Seats on Soyuz in 2020” | >

The super-charged face scanning tech is costing the military at least $4.3 million.

The United States Army is currently building a super-charged facial recognition system — tech that could be ready for action as soon as next year.

The system, as described in a new One Zero story, analyzes infrared images of a person’s face to see if they’re a match for anyone on a government watchlist, such as a known terrorist. Not only will the finished system reportedly work in the dark, through car windshields, and even in less-than-clear weather conditions — but it’ll also be able to ID individuals from up to 500 meters away.

Army Agreements

Continue reading “Army Developing Tech to ID Terrorists in the Dark From .5 KM Away” | >

As they increasingly log on from home, Americans are having to meld their personal technology with professional tools at unprecedented scale. For employers, the concern isn’t just about capacity, but also about workers introducing new potential vulnerabilities into their routine — whether that’s weak passwords on personal computers, poorly secured home WiFi routers, or a family member’s device passing along a computer virus.

The dramatic expansion of teleworking by US schools, businesses and government agencies in response to the coronavirus is raising fresh questions about the capacity and security of the tools many Americans use to connect to vital workplace systems and data.

At one major US agency, some officials have resorted to holding meetings on iPhone group calls because the regular conference bridges haven’t always been working, according to one federal employee. But the workaround has its limits: The group calls support only five participants at a time, the employee noted.

“Things have worked better than I anticipated, but there are lots of hiccups still,” said the employee, who spoke on condition of anonymity because he is not authorized to speak on the record.

Continue reading “Millions of Americans are suddenly working from home. That’s a huge security risk” | >

Possible treatments for coronavirus:

Remdesivir by the firm Gilead was developed to fight other viruses including Ebola (where it was shown to be ineffective) and it hasn’t yet been approved for treating anything. Still, it has shown early promise in treating some coronavirus patients in China, according to doctors, and manufacturer Gilead is moving ahead with final stage clinical trials in Asia. It has also been used to treat at least one US patient so far.

NIH’s Anthony Fauci, one of the top government scientists overseeing the coronavirus response, has said it could be available in the next “several months.”

WHO officials says progress being made, but any immunizing solution will take time: ‘There is only one thing more dangerous than a bad virus, and that’s a bad vaccine’

Continue reading “Over 20 vaccines, multiple treatments currently in development for coronavirus” | >